Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2289
https://www.valueinhealthjournal.com/article/S1098-3015(14)04219-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1750
First Page :
A637
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04219-3&doi=10.1016/j.jval.2014.08.2289